A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01).
Riccardi A, Pugliese P, Danova M, Brugnatelli S, Grasso D, Giordano M, Bernardo G, Giardina G, Fava S, Montanari G, Pedrotti C, Trotti G, Rinaldi E, Poli MA, Tinelli C.
Riccardi A, et al. Among authors: danova m.
Br J Cancer. 2001 Jul 20;85(2):141-6. doi: 10.1054/bjoc.2001.1897.
Br J Cancer. 2001.
PMID: 11461067
Free PMC article.
Clinical Trial.